Industries de la santé
New Tobacco-Based Influenza Vaccine Offers Promising Alternative to Traditional Egg-Based Versions, says GlobalData Analyst
11 Mars 2016
LONDON, UK (GlobalData), 10 March 2016 - A new tobacco-based seasonal influenza vaccine being developed by Mitsubishi Tanabe Pharma and currently in Phase III studies could potentially rival traditional chicken egg-based vaccines, as it aims to launch in the US for the 2018-19 flu season, according to an analyst with research and consulting firm GlobalData. |The technology involved in...
Plus d'articles...
- Burgeoning Global Telehealth Market Could Deliver Huge Savings to Government Healthcare Budgets, says GBI Research
- Actinium Pharmaceuticals Selects Medpace Inc. as Clinical Research Organization for Pivotal Phase 3 Iomab-B Trial
- Amedica and Celling Biosciences to Collaborate on Biologically Enhanced Spinal Fusion Devices
- EOS imaging et Stryker annoncent un accord de co-promotion au Royaume-Uni